Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Moore

Showing results (271-280 of 500) with videos related to

Pageof 50
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2017
Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United StatesStephen R Cole, Jessie K Edwards, H Irene Hall, et al.
AIDS (London, England)|July 25, 2012
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine careRobert C Kalayjian, Bryan Lau, Rhoderick N Mechekano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2023
The Association of HIV Control and Immunosuppression With Risk of Non-AIDS-Defining Cancer Risk Among Patients on Antiretroviral TherapyBrittney L Dickey, Elizabeth L Yanik, Zachary Thompson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2017
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine CareAngela M Bengtson, Brian W Pence, Katie R Mollan, et al.
Plos One|January 12, 2016
Geographic Variations in Retention in Care among HIV-Infected Adults in the United StatesPeter F Rebeiro, Stephen J Gange, Michael A Horberg, et al.
AIDS Care|July 28, 2018
Reconciling the evaluation of co-morbidities among HIV care patients in two large data systems: the Medical Monitoring Project and CFAR Network of Integrated Clinical SystemsJulia E Hood, Heather Bradley, James P Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2016
Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United StatesElizabeth L Yanik, Chad J Achenbach, Satish Gopal, et al.
Plos One|June 19, 2015
The HIV Care Continuum: Changes over Time in Retention in Care and Viral SuppressionBaligh R Yehia, Alisa J Stephens-Shields, John A Fleishman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 19, 2016
Poorly Controlled HIV Infection: An Independent Risk Factor for Liver FibrosisH Nina Kim, Robin Nance, Stephen Van Rompaey, et al.
Pharmacoepidemiology and Drug Safety|November 3, 2021
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and DesignJim Young, Vincent Lo Re, H Nina Kim, et al.
Pageof 50

Showing results (271-280 of 500) with videos related to

Sort By:
Pageof 50
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2017
Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United StatesStephen R Cole, Jessie K Edwards, H Irene Hall, et al.
AIDS (London, England)|July 25, 2012
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine careRobert C Kalayjian, Bryan Lau, Rhoderick N Mechekano, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2023
The Association of HIV Control and Immunosuppression With Risk of Non-AIDS-Defining Cancer Risk Among Patients on Antiretroviral TherapyBrittney L Dickey, Elizabeth L Yanik, Zachary Thompson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 28, 2017
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine CareAngela M Bengtson, Brian W Pence, Katie R Mollan, et al.
Plos One|January 12, 2016
Geographic Variations in Retention in Care among HIV-Infected Adults in the United StatesPeter F Rebeiro, Stephen J Gange, Michael A Horberg, et al.
AIDS Care|July 28, 2018
Reconciling the evaluation of co-morbidities among HIV care patients in two large data systems: the Medical Monitoring Project and CFAR Network of Integrated Clinical SystemsJulia E Hood, Heather Bradley, James P Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2016
Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United StatesElizabeth L Yanik, Chad J Achenbach, Satish Gopal, et al.
Plos One|June 19, 2015
The HIV Care Continuum: Changes over Time in Retention in Care and Viral SuppressionBaligh R Yehia, Alisa J Stephens-Shields, John A Fleishman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 19, 2016
Poorly Controlled HIV Infection: An Independent Risk Factor for Liver FibrosisH Nina Kim, Robin Nance, Stephen Van Rompaey, et al.
Pharmacoepidemiology and Drug Safety|November 3, 2021
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and DesignJim Young, Vincent Lo Re, H Nina Kim, et al.
Pageof 50